Table 2.
Microarray Detection of Genes Changing Expression with H2O2 Treatment CMCs or HFs were treated with 100 μM H2O2 for 1 hour and were placed in fresh culture medium for 24 hrs recovery before harvesting RNA for Affymetrix Gene Array Analyses (see Methods). The data indicates the averages and standard deviations of fold changes from 4 comparisons. The fold of increase or decrease (negative numbers in italic) for each comparison was determined by Microarray Suite 5.0.1 as statistically significant changes. The column in the table represents 1) Affymetrix sequence number, 2) UniGene number, 3) common name of the genes, 4) fold of changes in CMCs and 5) fold of changes in HFs.
Antioxidant/detoxification enzymes | CMCs | HFs | ||
---|---|---|---|---|
1387599a | Rn.11234 | NAD(P)H dehydrogenase, quinone 1 | 3.11±0.48 | 4.14±1.90 |
1370902 | Rn.23676 | aldose reductase-like protein | 3.06±0.52 | 4.02±1.26 |
1387669a | Rn.3603 | epoxide hydrolase 1 | 2.47±0.25 | 2.50±0.51 |
1372599 | Rn.7854 | microsomal glutathione S-transferase 2 | 2.31±0.26 | 2.26±0.68 |
1367612 | Rn.2580 | microsomal glutathione S-transferase 1 | 1.72±0.18 | 2.73±0.81 |
1388122 | Rn.44821 | glutathione S-transferase, pi 2 | 1.81±0.25 | 1.97±0.20 |
1369940 | Rn.3136 | transaldolase 1 | 1.99±0.36 | 2.31±0.26 |
1370678s | Rn.102240 | monoamine oxidase A gene | 1.92±0.35 | 1.60±0.05 |
1368990 | Rn.10125 | cytochrome P450 1B 1 (Cyp1b1) | 1.84±0.22 | 1.60±0.10 |
1370080 | Rn.3160 | Heme oxygenase | 2.22±0.49 | |
1387759s | Rn.26489 | UDP glycosyltransferase 1 family, A6 | 2.66±0.88 | |
1370613s | Rn.64664 | UDP glycosyltransferase 1 family, A7 | 2.21±0.40 | |
1369926 | Rn.1491 | glutathione peroxidase 3 | 1.87±0.13 | |
1367774 | Rn.10460 | glutathione S-transferase, α 1 | 1.81±0.16 | |
1372297 | Rn.15990 | glutathione S-transferase 8(GST class α) | 1.64±0.31 | |
1367995 | Rn.3001 | catalase | 1.58±0.19 | |
1370172 | Rn.10488 | superoxide dismutase 2 | 1.49±0.10 | |
1386958 | Rn.67581 | thioredoxin reductase 1 | 1.50±0.26 | |
1367870 | Rn.3578 | thioredoxin-like 2 | 1.38±0.05 | |
1367613 | Rn.2845 | peroxiredoxin 1 | 1.36±0.15 | |
1388300 | Rn.1916 | microsomal glutathione S-transferase 3 | −2.92±1.13 | |
1370708a | Rn.10021 | 3-α-hydroxysteroid dehydrogenase | −1.90±0.43 | |
1367979s | Rn.107152 | cytochrome P450, subfamily 51 | −1.47±0.13 | |
1387891 | Rn.17958 | peroxiredoxin 4 | −1.36±0.15 | |
Metal binding proteins | ||||
1368420 | Rn.32777 | ceruloplasmin | 1.99±0.73 | |
1367565a | Rn.54447 | ferritin, heavy polypeptide 1 | 1.38±0.11 | |
1367559 | Rn.1905 | ferritin light chain 1 | 1.32±0.11 | |
1370282 | Rn.94754 | cysteine rich protein 2 | −1.76±0.33 | |
Metabolic enzymes | ||||
1386953 | Rn.888 | hydroxysteroid 11-β dehydrogenase 1 | 2.38±0.78 | 3.37±1.58 |
1370154 | Rn.2283 | lysozyme | 1.73±0.36 | |
1367856 | Rn.11040 | glucose-6-phosphate dehydrogenase | 1.92±0.28 | |
1367982 | Rn.97126 | aminolevulinic acid synthase 1 | 1.80±0.34 | |
1387022 | Rn.6132 | aldehyde dehydrogenase family 1, A1 | 1.75±0.47 | |
1368976 | Rn.11414 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase, CD38 antigen |
1.72±0.29 | |
1386859 | Rn.5950 | transketolase | 1.55±0.22 | |
1372523 | Rn.8365 | glutamate-cysteine ligase catalytic subunit | 1.46±0.24 | |
1371521 | Rn.11126 | pyruvate dehydrogenase E1 α-like | 1.39±0.14 | |
1369931 | Rn.1556 | pyruvate kinase, muscle | 1.39±0.14 | |
1367734 | Rn.107801 | aldehyde reductase 1 (low Km aldose reductase) |
1.39±0.14 | |
1367739 | Rn.10325 |
Cytochrome c oxidase subunit VIII-H (heart/muscle) |
−4.71±3.19 | |
1367782 | Rn.5119 |
cytochrome c oxidase, subunit VIa, polypeptide 2 |
−2.97±1.37 | |
1367626 | Rn.10756 | creatine kinase, muscle | −2.44±0.96 | |
1369629 | Rn.3329 | adenosine kinase | −1.84±0.31 | |
1387773 | Rn.2202 | cytochrome c, somatic | −1.52±0.33 | |
1370276 | Rn.1817 |
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
−1.53±0.21 | |
1370278 | Rn.3879 |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
−1.49±0.22 | |
1370284 | Rn.3454 |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
−1.45±0.21 | |
1370230 | Rn.5790 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 |
−1.42±0.13 | |
1371335 | Rn.107458 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g |
−1.42±0.20 | |
1389964 | Rn.1318 |
NADH dehydrogenase (ubiquinone) (EC 1.6.5.3) acyl carrier chain, mitochondrial |
−1.53±0.21 | |
1371041 | Rn.11092 |
24-kDa subunit of mitochondrial NADH dehydrogenase |
−1.45±0.16 | |
1389012 | Rn.18013 |
NADH dehydrogenase (ubiquinone) 1 β subcomplex, 2 |
−1.46±0.24 | |
1389288 | Rn.14785 |
NADH dehydrogenase (ubiquinone) 1 α subcomplex, 2 (8kD, B8) |
−1.42±0.20 | |
1371381 | Rn.35208 |
Ubiquinol-cytochrome C reductase complex 7.2 kDa protein (HSPC119) |
−1.46±0.20 | |
1375197 | Rn.3254 |
Ubiquinol-cytochrome C reductase complex 6.4 kDa protein (Complex III subunit XI) |
−1.38±0.11 | |
1370218 | Rn.1785 | lactate dehydrogenase B | −1.83±0.54 | |
1370939 | Rn.6215 |
fatty acid Coenzyme A ligase, long chain 2 |
−1.80±0.54 | |
1367857 | Rn.28161 | fatty acid desaturase 1 | −1.69±0.23 | |
1386965 | Rn.3834 | Lipoprotein lipase | −1.58±0.11 | |
1367707 | Rn.9486 | fatty acid synthase | −1.45±0.17 | |
1388348 | Rn.4243 | fatty acid elongase 1 | −1.29 ± 0.05 | |
1370355 | Rn.1023 | stearoyl-Coenzyme A desaturase 1 | −1.78±0.25 | |
1367668a | Rn.83595 | stearoyl-Coenzyme A desaturase 2 | −1.76±0.25 | |
1370191 | Rn.6290 |
ornithine decarboxylase antizyme inhibitor |
−1.78±0.42 | |
1367667 | Rn.2622 | farensyl diphosphate synthase | −1.78±0.16 | |
1387271 | Rn.7279 | phytanoyl-CoA hydroxylase | −1.73±0.63 | |
1372462 | Rn.106162 | acetyl-CoA C-acetyltransferase, cytosolic | −1.71±0.37 | |
1370235 | Rn.3285 | diazepam binding inhibitor | −1.67±0.18 | |
1388403 | Rn.3490 |
Isocitrate dehydrogenase, cytoplasmic (Oxalosuccinate decarboxylase) |
−1.65±0.33 | |
1368878 | Rn.10780 | isopentenyl-diphosphate delta isomerase | −1.59±0.26 | |
1367932 | Rn.5106 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
−1.42±0.14 | |
1389908 | Rn.73738 | β-galactosidase (Lactase) | −1.42±0.10 | |
1372665 | Rn.100813 | Phosphoserine aminotransferase 1 | −1.32±0.09 | |
Endocrine factors, cytokines and binding factors | ||||
1367973 | Rn.4772 | small inducible cytokine A2 | 3.85±2.70 | 1.84±1.07 |
1370770s | Rn.44216 | Kit ligand, stem cell factor | 2.26±0.68 | 1.88±0.26 |
1368238 | Rn.9727 | pancreatitis-associated protein | 4.23±2.16 | |
1386879 | Rn.764 | lectin, galactose binding, soluble 3 | 3.22±1.24 | |
1371210s | Rn.39743 | MHC nonclassical class I antigen | 2.88±0.68 | |
1390507 | Rn.16103 | interferon stimulated gene (20kD) | 1.99±0.36 | |
1373882 | Rn.4256 | VEGF-D | 1.74±0.13 | |
1370082 | Rn.40136 | TGF β1 | 1.60±0.24 | |
1387450 | Rn.9952 | TGF α | 1.93±0.62 | |
1387316 | Rn.10907 | gro | 4.33±1.37 | |
1387029 | Rn.101777 | complement component factor H | 4.13±2.42 | |
1388255x | Rn.39743 | MHC nonclassical class I antigen, soluble precursor (RT1 class Ib gene) |
3.33±0.92 | |
1367850 | Rn.6050 | Fc receptor, IgG, low affinity III | 3.28±1.81 | |
1370154 | Rn.2283 | Lysozyme | 3.05±1.35 | |
1387687 | Rn.16316 | immunoglobulin superfamily, member 6 | 2.81±1.03 | |
1368490 | Rn.42942 | CD14 antigen | 1.56±0.22 | |
1368044 | Rn.45602 | secretogranin 2 | −3.87±2.38 | −2.73±1.15 |
1371500 | Rn.7961 | latent TGF β binding protein 1 | −1.83±0.15 | |
1387232 | Rn.10318 | bone morphogenetic protein 4 | −1.42±0.11 | |
1376425 | Rn.24539 | TGF β2 | −1.32±0.07 | |
1371500 | Rn.7961 |
latent TGF β binding protein 4 homologue (46%) |
−1.72±0.29 | |
1368448 | Rn.40921 | latent TGF β binding protein 2 | −1.46±0.20 | |
1367650 | Rn.1256 |
lipocalin 7 (glucocorticoid-inducible protein) |
−2.09±0.81 | |
1369519 | Rn.10918 | endothelin 1 | −1.56±0.50 | |
1368983 | Rn.10148 | heparin-binding EGF-like growth factor | −1.50±0.32 | |
1379375 | Rn.10999 | Platelet derived growth factor α | −1.39±0.14 | |
Receptors | ||||
1369146a | Rn.91370 | Aryl hydrocarbon receptor | 1.96±0.20 | 1.79±0.19 |
1367940 | Rn.12959 | chemokine orphan receptor 1 | 2.33±0.71 | |
1368742 | Rn.10680 | complement component 5, receptor 1 | 2.03±0.89 | |
1387273 | Rn.10072 | interleukin 1 receptor-like 1 | 1.55±0.22 | |
1367619 | Rn.102356 | progesterone receptor membrane component 1 |
1.49±0.15 | |
1367636 | Rn.270 | insulin-like growth factor 2 receptor | 1.45±0.11 | |
1370249 | Rn.1820 | benzodiazepin receptor | 1.42±0.20 | |
1371840 | Rn.4102 |
endothelial differentiation sphingolipid G-protein-coupled receptor 1 |
−4.15±2.29 | |
1370462 | Rn.92304 |
Hyaluronan mediated motility receptor (RHAMM) |
−3.08±0.93 | |
1373661a | Rn.44431 | Chemokine receptor (LCR1) | −1.83±0.54 | |
1373803a | Rn.2178 |
growth hormone receptor (somatotropin receptor precursor) |
−1.71±0.18 | |
1371113a | Rn.98672 | transferrin receptor | −1.49±0.35 | |
1370541 | Rn.10055 |
nuclear receptor subfamily 1, group D, member 2 |
−1.45±0.06 | |
1368553 | Rn.10631 | activin A receptor type II-like 1 | −1.38±0.05 | |
Signaling molecules | ||||
1370445 | Rn.10696 | phosphatidylserine-specific phospholipase A1 |
1.72±0.29 | 1.70±0.07 |
1387822 | Rn.21925 | G-protein α11 subunit | 1.52±0.11 | |
1368332 | Rn.25736 | guanylate binding protein 2, interferon- inducible |
2.25±0.23 | |
1368144 | Rn.1892 | regulator of G-protein signaling protein 2 | 2.20±0.61 | |
1372031 | Rn.14763 | Dab2: Disabled homolog 2, mitogen- responsive phosphoprotein |
1.75±0.47 | |
1370942 | Rn.23055 | RAS p21 protein activator 3 (49%) | 1.73±0.63 | |
1383180 | Rn.4016 | protein phosphatase 1, regulatory (inhibitor) subunit 2 |
1.53±0.21 | |
1369294 | Rn.10728 | bone marrow stromal cell antigen 1 (cyclic ADPribose metabolism) |
1.51±0.27 | |
1371353 | Rn.107103 | sequestosome 1 | 1.37±0.05 | |
1372017 | Rn.9090 | Direct IAP binding protein with low pI | 1.37±0.12 | |
1373658 | Rn.19950 | Rac GTPase-activating protein 1 | −5.44±2.20 | |
1375303 | Rn.17340 | enigma | −2.60±0.94 | |
1371984 | Rn.17340 | enigma homolog | −2.15±1.01 | |
1371873 | Rn.4268 | lecuine-rich acidic protein-like protein | −2.04±0.18 | |
1372084 | Rn.106043 |
tyrosine phosphatase type IVA, member 3 isoform 1 |
−1.63±0.37 | |
1368101 | Rn.2892 | calmodulin 3 | −1.52±0.00 | |
1370829 | Rn.8873 | farnesyltransferase β subunit | −1.70 ± 0.42 | |
1373082 | Rn.94808 | Pkia: Protein kinase inhibitor, α | −1.42±0.20 | |
1370012 | Rn.73051 | prostaglandin I2 synthase | −1.36±0.15 | |
1369097s | Rn.87228 | guanylate cyclase 1, soluble,β3 | −1.35±0.05 | |
Cell cycle regulators | ||||
1387391 | Rn.10089 | cyclin-dependent kinase inhibitor 1A, p21 | 3.9±1.10 | 4.92±2.82 |
1383485 | Rn.91829 | Mdm2 | 1.99±0.36 | |
1367764 | Rn.5834 | cyclin G1 | 1.56±0.26 | |
1373823 | Rn.6116 | cell division control protein CKS2 | −4.08±1.24 | −1.83±0.19 |
1367671 | Rn.223 | Proliferating cell nuclear antigen | −2.01±0.25 | −1.52±0.15 |
1373557 | Rn.8341 | replication licensing factor MCM4 | −2.48±0.63 | −1.55±0.12 |
1375532 | Rn.3272 |
Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
−1.83±0.55 | −1.47±0.13 |
1374775 | Rn.12774 | cell proliferation antigen Ki-67 | −20.5±15.0 | |
1367776 | Rn.6934 | cell division cycle 2 homolog A | −4.74±0.86 | |
1372685 | Rn.25026 | cyclin-dependent kinase inhibitor 3 | −4.71±1.18 | |
1370346 | Rn.9232 | Cyclin B1 | −3.79±1.35 | |
1389566 | Rn.23351 | strong similarity to cyclin B2 | −3.68±0.88 | |
1388395 | Rn.1040 |
Putative lymphocyte G0/G1 switch protein 2 |
−2.53±1.25 | |
1374449 | Rn.3246 |
cell division cycle associated 3; gene rich cluster, C8 gene; |
−2.31±0.29 | |
1371074a | Rn.33226 | mini chromosome maintenance deficient 6 | −2.25±0.64 | |
1367894 | Rn.772 | growth response protein (CL-6) | −1.91±0.20 | |
1370294a | Rn.9262 | cell cycle protein p55CDC | −1.81±0.37 | |
1372406 | Rn.12916 | replication licensing factor MCM3 | −1.63±0.17 | |
1367657 | Rn.1000 | B-cell translocation gene 1 | −1.29±0.11 | |
1369935 | Rn.3483 | cyclin D3 | −1.39±0.21 | |
Cytoskeletal proteins and their regulators | ||||
1372750 | Rn.2743 | Follistatin | 1.91±0.20 | 2.30±0.87 |
1388460 | Rn.8945 | macrophage capping protein | 2.10±0.07 | |
1371618s | Rn.8216 | tubulin, β3 | 1.93±0.32 | |
1386857 | Rn.555 | stathmin 1 | −3.64±0.60 | −1.96±0.39 |
1367785 | Rn.31788 | Calponin 1 | −2.04±0.21 | −1.53±0.26 |
1371339 | Rn.11675 | cofilin 1 | −2.76±1.35 | |
1388718 | Rn.1646 | tropomodulin 1 | −2.39±0.76 | |
1387373 | Rn.48693 | myomegalin | −1.79±0.59 | |
1370875 | Rn.773 | villin 2 | −1.52±0.11 | |
1370949 | Rn.9560 |
myristoylated alanine rich protein kinase C substrate |
−1.39±0.21 | |
1368822 | Rn.95652 | follistatin-like | −1.33±0.16 | |
Cell surface and extracellular matrix proteins | ||||
1367581a | Rn.8871 | secreted phosphoprotein 1 | 2.25±0.67 | 2.19±0.55 |
1374620 | Rn.91235 | Ceacam1 | 2.10±0.17 | |
1388985 | Rn.25004 | Collagen α1(V) homologue | 1.72±0.29 | |
1389966 | Rn.2157 | Collagen α3 (VI) homologue | 1.49±0.13 | |
1393891 | Rn.53843 | Collagen α1(VIII) homologue | 1.32±0.07 | |
1386879 | Rn.764 | lectin, galactose binding, soluble 3 | 2.06±0.86 | |
1368187 | Rn.13778 | glycoprotein (transmembrane) nmb | 2.05±0.76 | |
1367784a | Rn.1780 | clusterin | 1.91±0.20 | |
1368474 | Rn.11267 | Vascular cell adhesion molecule 1 | 1.80±0.25 | |
1370043 | Rn.5789 | activated leukocyte cell adhesion molecule |
1.37±0.16 | |
1392784 | Rn.52228 | growth arrest specific 6 | 1.35±0.11 | |
1369943 | Rn.10 | tissue-type transglutaminase | −2.04±0.48 | −1.81±0.25 |
1388111 | Rn.54384 | elastin | −1.80±0.39 | −3.23±2.46 |
1368171 | Rn.11372 | lysyl oxidase | −1.64±0.31 | −1.69±0.40 |
1387850 | Rn.44829 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
−3.21±1.23 | |
1388961 | Rn.39792 | integrin β1 binding protein (melusin) 2 | −3.00±1.84 | |
1370937a | Rn.54492 | integrin α7 | −2.00±0.71 | |
1373897 | Rn.11362 | lamin B1 | −2.99±0.31 | |
1373439 | Rn.6499 | lamin B receptor | −1.52±0.11 | |
1381504 | Rn.45067 |
Biglycan precursor (Bone/cartilage proteoglycan I) (PG-S1) |
−1.42±0.10 | |
1373401 | Rn.12723 | tenascin C | −2.49±1.37 | |
1369736 | Rn.19723 | Epithelial membrane protein 1 | −1.80±0.31 | |
1387280a | Rn.32261 | tumor-associated protein 1 | −1.57±0.32 | |
1367880 | Rn.774 | laminin, β2 | −1.39±0.21 | |
1369955 | Rn.117 | collagen, type V, α1 | −1.35±0.11 | |
Muscle protein and contractile proteins | ||||
1368415 | Rn.9692 |
Myosin heavy chain, skeletal muscle, perinatal |
−14.38±4.05 | |
1367928 | Rn.48663 |
myosin heavy chain, polypeptide 7, cardiac muscle, β |
−3.87±2.42 | |
1371293 | Rn.23925 | Myosin light chain 1, atrial isoform | −4.83±1.98 | |
1367572 | Rn.1955 | myosin, light chain polypeptide 3 | −2.57±1.50 | |
1376789 | Rn.43838 | myosin-light-chain kinase | −2.12±0.82 | |
1388298 | Rn.6870 |
Myosin regulatory light chain 2, smooth muscle isoform |
−1.38±0.05 | |
1369928 | Rn.82732 | actin α 1 | −3.05±2.04 | |
1386931 | Rn.64141 | troponin 1, type 3 | −2.88±1.68 | |
1386873 | Rn.4035 | Troponin I, slow isoform | −2.55±0.94 | |
1388604 | Rn.38090 | Calsequestrin, cardiac muscle isoform | −3.82±1.91 | |
1371801 | Rn.12931 |
calcineurin-binding protein calsarcin-1; muscle-specific protein; FATZ related protein 2 |
−3.58±1.81 | |
1368988 | Rn.10111 | calsequestrin 2 | −2.36±1.03 | |
1398243 | Rn.11345 |
cysteine-rich protein 3; muscle LIM protein |
−3.17±1.69 | |
1370165 | Rn.4123 | small muscle protein, X-linked | −2.60±0.94 | |
1368252 | Rn.28875 | sarcomeric muscle protein | −2.30±0.82 | |
1372527 | Rn.3210 |
Rtn2: Reticulon 2 (Z-band associated protein) |
−2.27±0.76 | |
1390049 | Rn.34417 | four and a half LIM domains 1 | −2.12±0.93 | |
1371933 | Rn.48693 | myomegalin | −1.57±0.29 | |
Channel proteins | ||||
1370583s | Rn.82691 | P-glycoprotein, multidrug resistance 1 | 5.02±1.52 | 4.72±1.64 |
1368207 | Rn.24997 | FXYD domain-containing ion transport regulator 5 |
1.73±0.36 | |
1367959a | Rn.4958 | sodium channel, voltage-gated, type I, β | 2.89±1.33 | |
1370516 | Rn.17317 | peptide/histidine transporter PHT2 | 2.14±0.79 | |
1373054 | Rn.97686 | Ctl1: Transporter-like protein | 1.43±0.23 | |
1367683 | Rn.2949 | karyopherin (importin) α2 | −1.62±0.0 | −1.64±0.31 |
1369960 | Rn.3828 |
FXYD domain-containing ion transport regulator 1 |
−2.60±1.27 | |
1368965 | Rn.10826 | monocarboxylate transporter | −2.36±0.65 | |
1386901 | Rn.3790 |
fatty acid binding/transport protein (cd36 antigen) |
−2.60±1.52 | |
1367660 | Rn.32566 | fatty acid binding protein 3 | −2.06±0.73 | |
1370281 | Rn.98269 | fatty acid binding protein 5, epidermal | −1.45±0.20 | |
1370850 | Rn.3402 | sodium channel β3 subunit | −2.63±1.51 | |
1369625 | Rn.1618 | aquaporin 1 | −2.38±1.27 | |
1369065a | Rn.2305 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
−1.87±0.70 | |
1371883 | Rn.34134 | solute carrier family 1, member 3 | −1.85±0.23 | |
1389967 | Rn.3366 |
ADP-ribosylation-like factor 6- interacting protein |
−1.50±0.15 | |
1398370 | Rn.45761 | rexo70 | −1.82±0.45 | |
1389986 | Rn.58137 | synaptic vesicle glycoprotein 2 b | −1.46±0.24 | |
Protease or protease inhibitors | ||||
1368590 | Rn.52536 | matrix metalloproteinase 16 | 1.79±0.19 | |
1368530 | Rn.33193 | matrix metalloproteinase 12 | 2.15±0.82 | |
1368512a | Rn.53979 | aminopeptidase A | 2.24±0.92 | |
1387005 | Rn.11347 | cathepsin S | 2.24±0.92 | |
1368280 | Rn.11559 | cathepsin C | 2.01±0.54 | |
1368215 | Rn.43558 | ceroid-lipofuscinosis, neuronal 2 | 1.42±0.18 | |
1369977 | Rn.107213 | ubiquitin carboxy-terminal hydrolase L1 | 1.39±0.21 | |
1368544a | Rn.86956 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
1.32±0.09 | |
1389408 | Rn.99540 |
neural precursor cell expressed, developmentally down-regulated gene 4A |
−5.78±0.52 | −3.55±1.36 |
1372440 | Rn.2271 |
serine (or cysteine) proteinase inhibitor, clade E, member 2 |
−1.60±0.48 | −1.80±0.25 |
1370064 | Rn.11045 | presenilin-2 | −1.42±0.20 | −1.38±0.05 |
1387804 | Rn.40636 |
muscle ring finger protein 1; ring finger protein 28 |
−1.97±0.56 | |
1368961 | Rn.22562 | Matrix metalloproteinase 23 | −1.28±0.05 | |
1368519 | Rn.29367 |
serine (or cysteine) proteinase inhibitor, member 1 |
−1.75±0.50 | |
Nucleic acid metabolism | ||||
1368311 | Rn.9836 | O6-methylguanine-DNA methyltranferase | 1.97±0.17 | 1.36±0.15 |
1387659 | Rn.24783 | guanine deaminase | 1.91±0.27 | |
1371862 | Rn.22094 |
Ribonucleoside-diphosphate reductase M1 chain (Ribonucleotide reductase large chain). |
−2.64±0.15 | |
1387865 | Rn.6102 | Deoxyuridinetriphosphatase (dUTPase) | −1.69±0.15 | |
1373772 | Rn.6955 | DNA (cytosine-5)-methyltransferase 1 | −1.63±0.11 | |
Chromosomal or DNA binding proteins | ||||
1388309 | Rn.83614 | non-histone chromosomal architectural protein HMGI-C |
1.75±0.22 | |
1374293 | Rn.40496 | Histone H2A.l | 1.49±0.22 | |
1367676 | Rn.2874 | high mobility group box 2 | −2.93±0.19 | −1.56±0.28 |
1368136 | Rn.3364 | lamina-associated protein 2 | −2.04±0.21 | −1.73±0.38 |
1386861 | Rn.3636 | H2A histone family, member Z | −1.62±0.09 | −1.30±0.04 |
1388827 | Rn.100938 |
H2A histone family, member V (predicted) |
−1.48±0.24 | |
1372516 | Rn.8601 | kinesin-like 4; Kid; | −2.89±0.34 | |
1388135 | Rn.40389 | p32-subunit of replication protein A | −2.00±0.11 | |
1371887 | Rn.13669 |
high-mobility group (nonhistone chromosomal) protein 4 |
−1.66±0.17 | |
1371352 | Rn.3517 | high mobility group protein 17 | −1.58±0.19 | |
1368042a | Rn.4121 | high mobility group box 1 | -1.39±0.14 | |
1388504 | Rn.3991 |
RAD21 homolog; protein involved in DNA double-strand break repair; nuclear matrix protein 1 |
−1.46±0.06 | |
1369996 | Rn.28212 | polymerase II | −1.37±0.05 | |
1367666 | Rn.23677 |
heterogeneous nuclear ribonucleoprotein H1 |
−1.36 ± 0.15 | |
Transcription factors | ||||
1387087 | Rn.6479 | CCAAT/enhancer binding protein (C/EBP) β |
1.50±0.26 | |
1376569 | Rn.114645 | Kruppel-like factor 2 | −1.38±0.11 | −1.95±0.28 |
1389555 | Rn.14867 | transcription factor 19 (SC1) | −3.03±0.61 | |
1389528s | Rn.93714 |
v-jun sarcoma virus 17 oncogene homolog |
−1.72±0.26 | |
1388426 | Rn.95306 | sterol regulatory element binding factor 1 | −1.57±0.32 | |
1387769a | Rn.2760 |
Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
−1.46±0.20 | |
1367664 | Rn.3789 | ankyrin-like repeat protein | −1.99±0.91 | |
1374335 | Rn.8701 | GATA binding protein 6 | −1.44±0.09 | |
Protein synthesis and conformation | ||||
1371378 | Rn.4113 | Protein translation factor SUI1 homolog | −1.26±0.05 | |
1371421 | Rn.98472 |
translation elongation factor eEF-1 α chain |
−1.81±0.56 | |
1372431 | Rn.105932 | mitochondrial ribosomal protein L12 | −1.37±0.12 | |
1370007 | Rn.39305 |
protein disulfide isomerase related protein (calcium-binding protein, intestinal-related) |
−1.38±0.05 | |
Stress genes | ||||
1387047 | Rn.20155 | heat shock 27kD protein family, 3 | −3.79±2.62 | |
Miscellaneous | ||||
1388674 | Rn.36610 | tumor protein, translationally-controlled 1 | 3.08±0.11 | 2.46±0.70 |
1370459 | Rn.38451 | A5D3 protein | 2.46±0.0 | 1.45±0.16 |
1369008a | Rn.11005 | olfactomedin related ER localized protein | 1.78±0.12 | 1.57±0.06 |
1373932 | Rn.98491 | Cybb: Endothelial type gp91-phox gene | 2.93±1.42 | |
1368006 | Rn.24799 | lysosomal-associated protein transmembrane 5 |
2.39±0.76 | |
1389210 | Rn.14256 | lymphocyte cytosolic protein 1 | 2.36±0.84 | |
1390383 | Rn.101967 | Adipose differentiation-related protein | 1.73±0.41 | |
1371131a | Rn.2758 | upregulated by 1,25-dihydroxyvitamin D- 3 |
1.69±0.15 | |
1368013 | Rn.19672 | Smhs1 protein | 1.66±0.42 | |
1387946 | Rn.3251 | peptidylprolyl isomerase C-associated protein |
1.59±0.32 | |
1367881 | Rn.53971 | protein tyrosine phosphatase, non- receptor type substrate homolog |
1.51±0.27 | |
1387081 | Rn.6133 | reticulocalbin 2 | 1.42±0.18 | |
1390325 | Rn.11414 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (CD38) |
1.38±0.05 | |
1387770 | Rn.3867 | Interferon α-inducible protein 27-like | 1.23±0.0 | |
1370697a | Rn.107975 | nexilin | −1.63±0.18 | −1.64±0.31 |
1374672 | Rn.3434 | cardiac ankyrin repeat kinase | −7.97 ± 7.22 | |
1370805 | Rn.8163 | melanocyte-specific gene 1 protein | −5.97±2.34 | |
1390137 | Rn.20235 | TRAF4 associated factor 1 homolog | −5.42±3.32 | |
1372886 | Rn.39396 |
Transforming acidic coiled-coil- containing protein 3 |
−3.71±1.36 | |
1377190 | Rn.12822 |
transcription activator of D-serine dehydratase |
−3.66±1.29 | |
1387957a | Rn.24200 | SH3-domain kinase binding protein 1 | −3.23 ± 1.50 | |
1372065 | Rn.4077 | ADP-ribosyltransferase 3 | −2.60±0.94 | |
1376084a | Rn.24582 | extra spindle poles like 1 | −2.47±0.54 | |
1372296 | Rn.4128 |
SH3 domain-binding glutamic acid-rich protein (21-glutamic acid-rich protein) |
−2.44±1.07 | |
1372646 | Rn.16593 | esophageal cancer related gene 4 protein | −1.99±0.34 | |
1368174 | Rn.10994 | EGL nine homolog 3 (C. elegans) | −1.85±0.39 | |
1368566a | Rn.6452 |
MIPP65 protein (mitochondrial phosphoprotein) |
−1.85±0.40 | |
1370828 | Rn.17310 | zinc finger, DHHC domain containing 2 | −1.85±0.28 | |
1372106 | Rn.7379 | pincher | −1.61±0.34 | |
1370176 | Rn.26957 |
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 3 |
−1.57±0.29 | |
1374951 | Rn.45300 |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
−1.50±0.26 | |
1371365 | Rn.3460 | ubiquitin carrier protein E2 | −1.48±0.24 | |
1370189 | Rn.8538 |
splicing factor, arginine/serine-rich (transformer 2 Drosophila homolog) 10 |
−1.42±0.18 | |
1371358 | Rn.3380 | synaptic glycoprotein SC2 (32%) | −1.42±0.20 | |
1370252 | Rn.13633 | Esau | −1.39±0.14 | |
1370062 | Rn.2084 | hypoxia induced gene 1 | −1.39±0.14 | |
1376749 | Rn.12119 | osteoinductive factor | −1.32±0.09 | |
1371298 | Rn.6171 | H19 fetal liver mRNA | −1.26±0.05 | |
1376198 | Rn.40141 |
visceral adipose tissue-specific transmembrane protein OL-16 |
−1.79 ± 0.74 | |
1370248 | Rn.839 |
FXYD domain-containing ion transport regulator 6 |
−1.52 ± 0.42 | |
1367604 | Rn.4267 | cysteine-rich protein 2 | −1.50 ± 0.23 | |
1373195 | Rn.9404 | orphan seven transmembrane receptor | −1.42 ± 0.10 | |
1370000 | Rn.41602 | NEFA precursor | −1.39 ± 0.21 | |
1367744 | Rn.11984 | melanoma antigen, family D, 2 | −1.33 ± 0.16 |